tirzepatide gastroparesis case report Gastrointestinal adverse events and weight reduction in people with type 2 diabetes treated with in the SURPASS clinical trials - Patel - 2024 - Diabetes, Obesity and Metabolism A 32-year-old man developed gastroparesis
Description
Kidney injury: Tirzepatide can cause severe diarrhea and vomiting, which can result in severe dehydration
Situations Where Tirzepatide May Be Recommended Tirzepatide may be considered for patients who need stronger appetite control or who have struggled to achieve results with previous weight loss medications
:max_bytes(150000):strip_icc()/VWH-GettyImages-1692436619-6afbd0305e5e42359effc8b3deda6818.jpg)
Women who become pregnant on tirzepatide should discontinue immediately and consult their healthcare provider
This is not rigid
Clinical pharmacology review (NDA 215866)
With a meal, with your protein shake, or in water on its own
